Biopharma · FDA Approvals · Stock
SOPH SOPHiA Genetics
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnost…
Assets on file: PrGIS
Catalyst calendar
Dated catalysts for SOPH, including recently decided ones.
Nothing scheduled in this window.
Recent first-hand events
Every first-hand event for SOPH, newest first.
SOPHSOPHiA GeneticsSOPHiA GENETICS and Myriad Genetics collaborate on PrGIS for prostate cancer
SOPHiA GENETICS and Myriad Genetics announced a collaboration to advance prostate cancer-specific genomic instability score (PrGIS) technology. The partnership supports precision oncology approaches with AstraZeneca. This is a new research alliance focused on advancing the technology.
Peers by market cap
Companies in the same sector closest to SOPH in market value.
ENTXEntera BioMarket cap $528.1M · 1 tracked drug · 1 upcoming catalyst
NGNENeurogeneMarket cap $521.9M · 1 tracked drug · 1 upcoming catalyst
AQSTAquestiveMarket cap $512.1M · 1 tracked drug
MDXGMiMedxMarket cap $545.8M · 1 tracked drug
ARVNArvinasMarket cap $494.0M · 2 tracked drugs · 5 upcoming catalysts
ACRSAclarisMarket cap $560.8M · 1 tracked drug
CBIOCrescent BiopharmaMarket cap $489.2M · 1 tracked drug · 4 upcoming catalysts
MNPRMonoparMarket cap $485.6M · 1 tracked drug